Re: note to Sharon and Zee
- From: jason@xxxxxxxxxx (Jason)
- Date: Sat, 09 Jul 2005 09:38:33 -0700
In article <rLqdnVQVLolVrVLfRVn-iw@xxxxxxxxxxx>, "Sharon Hope"
<shope@xxxxxxxx> wrote:
> Jason and Hawki,
> Forgive me for chiming in here, I realize the question wasn't directed to
> me, but I have an opinion here.
>
> Both JAMA and BJM have stated in editorials that they have, in the past,
> discriminated against articles showing adverse effects, and for articles
> funded by the pharmco industry.
>
> Each of these two distinguished journals ran a full edition on the bias
> they, themselves, found in their own articles.
>
> Think about it. For Lipitor alone, there are between 6 and 10 BILLION
> DOLLARS PER YEAR at stake. That company needs to answer to its
> stockholders, as do all the others.
>
> If the rules of the game permit:
> - direct to the consumer advertising
> - bribing doctors with goods, services, cash and travel
> - creating studies that showcase the product
> - 'packing' the peer juries with reviewers who are favorable to their
> product
> - ensuring favorable editorial viewpoints with massive journal advertising
> budgets
> - 'packing' the influential association boards with doctors who are
> favorable to their product or on their payroll
> - tracking every single prescription written by every single doctor
> - running web bots daily to identify any discussion of adverse effects
> - data-mining leftover findings from other studies to write up short studies
> with splashy headline attention-getting findings to counter-spin the issue
> getting attention in the web newsgroups
>
> That is exactly what they are going to do.
>
> That is EXACTLY WHAT THEY ARE DOING.
>
> That is also, ethics and morality aside, what they must do to retain favor
> with their stockholders.
>
> Unless and until Congress changes the rules, by:
>
> 1) Funding the FDA so that the agency is not dependent upon Pharmco user
> fees for over two-thirds of its budget (and making FDA answerable to the
> group that funds it)
>
> 2) Ensuring the NIH re-establishes its ethics policy with reporting and
> public view
>
> 3) Halting direct to consumer marketing
>
> 4) Halting bribing of the doctors
>
> 5) Requiring that all adverse events findings be made public once a drug is
> approved for marketing to the public
>
> 6) Providing a public forum for publishing non-industry funded studies (If
> the Public paid for the study, it is absurd that it never gets published
> because the journal peer reviewers don't like the findings)
>
> there will be no changes to the terrible safety record of the current crop
> of drugs.
>
> We need to make our preferences known to our elected officials.
Sharon,
As usual, another excellent post. I visited a public library a couple of
weeks ago and saw some past copies of JAMA. It was obvious that they made
sure they screened out by their review process any articles written by
alternative (MD) doctors. Your post provided some info. that I have not
seen anywhere else. It was helpful. I wonder if Hawki is aware of the
facts you mentioned in your post?
Thanks again,
Jason
--
NEWSGROUP SUBSCRIBERS MOTTO
We respect those subscribers that ask for advice or provide advice.
We do NOT respect the subscribers that enjoy criticizing people.
.
- Follow-Ups:
- Re: note to Sharon and Zee
- From: Hawki63
- Re: note to Sharon and Zee
- References:
- note to Sharon and Zee
- From: Jason
- Re: note to Sharon and Zee
- From: Hawki63
- Re: note to Sharon and Zee
- From: Jason
- Re: note to Sharon and Zee
- From: Hawki63
- Re: note to Sharon and Zee
- From: Jason
- Re: note to Sharon and Zee
- From: Jason
- Re: note to Sharon and Zee
- From: Sharon Hope
- note to Sharon and Zee
- Prev by Date: Re: note to Sharon and Zee
- Next by Date: Re: Question for Sharon
- Previous by thread: Re: note to Sharon and Zee
- Next by thread: Re: note to Sharon and Zee
- Index(es):
Relevant Pages
|